Update shared on 10 Nov 2025
Fair value Decreased 1.17%Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
What's in the News
- Emami's Board of Directors is scheduled to meet on November 10, 2025 to review and approve the unaudited standalone and consolidated financial results for the quarter ending September 30, 2025 (Key Developments).
- The Board will also consider the declaration of an interim dividend for the financial year 2025-26 at the upcoming meeting (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has decreased marginally from ₹706.24 to ₹697.96.
- Discount Rate has fallen slightly, moving from 14.10% to 13.52%.
- Revenue Growth projections have edged down from 8.39% to 8.30%.
- Net Profit Margin estimate has decreased from 22.81% to 22.73%.
- Future P/E has dropped modestly from 41.46x to 40.61x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.